Benitec Biopharma(BNTC) - 2024 Q1 - Quarterly Report

Title of each classTrading Symbol(s)Name of each exchange on which registered UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 For the quarterly period ended September 30, 2023 Delaware 84-462-0206 (State or other jurisdiction of incorporation or organization)(IRS Employer Identification No.) Table of Contents Emerging growth company ☐ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to 3940 Trust Way, ...